{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T21:23:53Z","timestamp":1783200233833,"version":"3.54.6"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T00:00:00Z","timestamp":1736121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T00:00:00Z","timestamp":1736121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002386","name":"Cairo University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002386","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Vitiligo is a common long-term depigmenting skin disorder that is characterized by patches of skin losing their pigment. To evaluate serum\/tissue levels of miR-16, 146a, 19b and 720 in vitiligo patients and healthy controls, also analyzing the correlations between all biomarkers to indicate whether those can be used to early diagnose vitiligo patients. Forty-subjects were included, divided into two equal groups, 20 healthy matched individuals and 20 vitiligo patients. For all groups a 5\u00a0mL venous blood sample for serum isolation was taken and analyzed for the serum level of miRNAs. For tissue analysis, 3\u00a0mm biopsy was taken. For all patients Vitiligo area scoring index (VASI), vitiligo disease activity (VIDA), disease duration and extent percentages were calculated. No significant difference was observed in age and sex ratio among the two groups (p\u2009&gt;\u20090.05). Serum, expression levels for miR-16, 146a, and 19b were overexpressed in vitiligo patients as compared to healthy controls with p-value 0.000 for all biomarkers. While miR-720 was reported low in vitiligo patients compared to controls (p\u2009=\u20090.000). For tissue samples, miR-16, 146a, 19b were overexpressed in vitiligo patients with p-values 0.000, 0.000 and &lt;\u20090.001 respectively, while for the expression level of miR-720 in tissue, the level was low compared to controls (p\u2009=\u20090.000). There are positive correlations between VASI and miR-16, 146a in serum and miR-146a in tissue. Also positive correlations between disease extent and both miR-16 and miR-146a in serum and in tissue was found. A negative correlation between VIDA and miR-720 in serum was found. Various correlations between the selected miRNAs were reported. Based upon the expression levels of miR-16, 146a, 19b and 720 in both serum and tissue, these biomarkers can be used as early indicators for vitiligo.<\/jats:p>","DOI":"10.1038\/s41598-024-83489-y","type":"journal-article","created":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T18:04:05Z","timestamp":1736186645000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Role of miR-16, 146a, 19b and 720 gene expressions in the pathogenesis and diagnosis of vitiligo"],"prefix":"10.1038","volume":"15","author":[{"given":"Olfat G.","family":"Shaker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talal A.","family":"Abd elrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somia","family":"Azzam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai Mohamed","family":"El-Zook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nesreen M.","family":"Aboraia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,6]]},"reference":[{"issue":"4","key":"83489_CR1","doi-asserted-by":"publisher","first-page":"247","DOI":"10.5114\/pdia.2014.43497","volume":"31","author":"R Czajkowski","year":"2014","unstructured":"Czajkowski, R. & M\u0119ci\u0144ska-Jundzi\u0142\u0142, K. Current aspects of vitiligo genetics. Postepy dermatologii i alergologii 31(4), 247\u2013255 (2014).","journal-title":"Postepy dermatologii i alergologii"},{"issue":"3","key":"83489_CR2","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/exd.14487","volume":"31","author":"N Raia","year":"2022","unstructured":"Raia, N., Shaker, O. G., Hassan, Z. M. & Abd Elrahim, T. A. Is there a relation between long non-coding RNA MALAT-1 and miRNA-9 in Egyptian patients with Vitiligo?. Exp. Dermatol. 31(3), 381\u2013383 (2022).","journal-title":"Exp. Dermatol."},{"issue":"1","key":"83489_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jaci.2013.04.011","volume":"132","author":"A Rebane","year":"2013","unstructured":"Rebane, A. & Akdis, C. A. MicroRNAs: Essential players in the regulation of inflammation. J. Allergy Clin. Immunol. 132(1), 15\u201326 (2013).","journal-title":"J. Allergy Clin. Immunol."},{"issue":"11","key":"83489_CR4","doi-asserted-by":"publisher","first-page":"6117","DOI":"10.3390\/ijms23116117","volume":"23","author":"JS Lee","year":"2022","unstructured":"Lee, J. S. et al. MicroRNA-365a\/b-3p as a potential biomarker for hypertrophic scars. Int. J. Mol. Sci. 23(11), 6117 (2022).","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"83489_CR5","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.23648","volume":"35","author":"Z Zhang","year":"2021","unstructured":"Zhang, Z. et al. Differentially expressed microRNAs in peripheral blood mononuclear cells of non-segmental vitiligo and their clinical significance. J. Clin. Lab. Anal. 35(2), e23648 (2021).","journal-title":"J. Clin. Lab. Anal."},{"issue":"3","key":"83489_CR6","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1002\/hep.29573","volume":"67","author":"Z Lu","year":"2018","unstructured":"Lu, Z. et al. MiR-15a\/16-1 suppresses AHR-dependent IL-22 secretion in CD4+ T cells and contributes to immune-mediated organ injury. Hepatology 67(3), 1027\u20131040 (2018).","journal-title":"Hepatology"},{"issue":"9","key":"83489_CR7","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1016\/j.jid.2017.05.012","volume":"137","author":"H Hermann","year":"2017","unstructured":"Hermann, H. et al. miR-146b probably assists miRNA-146a in the suppression of keratinocyte proliferation and inflammatory responses in psoriasis. J. Investig. Dermatol. 137(9), 1945\u20131954 (2017).","journal-title":"J. Investig. Dermatol."},{"issue":"1","key":"83489_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.4049\/jimmunol.1900027","volume":"203","author":"RL Riding","year":"2019","unstructured":"Riding, R. L. & Harris, J. E. The role of memory CD8+ T cells in vitiligo. J. Immunol. 203(1), 11\u201319 (2019).","journal-title":"J. Immunol."},{"issue":"12","key":"83489_CR9","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1111\/j.1468-3083.2012.04505.x","volume":"26","author":"KM Alghamdi","year":"2012","unstructured":"Alghamdi, K. M., Kumar, A., Ta\u00efeb, A. & Ezzedine, K. Assessment methods for the evaluation of vitiligo. J. Eur. Acad. Dermatol. Venereol. JEADV 26(12), 1463\u20131471 (2012).","journal-title":"J. Eur. Acad. Dermatol. Venereol. JEADV"},{"key":"83489_CR10","first-page":"160","volume":"2","author":"O Dicle","year":"2015","unstructured":"Dicle, O. Assessment methods in vitiligo. Pigment. Disord. 2, 160 (2015).","journal-title":"Pigment. Disord."},{"issue":"7","key":"83489_CR11","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1007\/s00403-023-02586-6","volume":"315","author":"NH Moftah","year":"2023","unstructured":"Moftah, N. H., Alnos, H., Rashed, L. & Hamdino, M. Evaluation of serum and tissue levels of cold-inducible RNA-binding protein in non-segmental Vitiligo. Arch. Dermatol. Res. 315(7), 2065\u20132071 (2023).","journal-title":"Arch. Dermatol. Res."},{"issue":"13","key":"83489_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108552","volume":"33","author":"E Hulstaert","year":"2020","unstructured":"Hulstaert, E. et al. Charting extracellular transcriptomes in the human biofluid RNA atlas. Cell Rep. 33(13), 108552 (2020).","journal-title":"Cell Rep."},{"key":"83489_CR13","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1111\/pcmr.12086","volume":"26","author":"YL Shi","year":"2013","unstructured":"Shi, Y. L. et al. MicroRNA expression profiling identifies potential serum biomarkers for non-segmental vitiligo. Pigment Cell Melanoma Res. 26, 418\u2013421 (2013).","journal-title":"Pigment Cell Melanoma Res."},{"issue":"2","key":"83489_CR14","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/exd.12319","volume":"23","author":"YL Shi","year":"2014","unstructured":"Shi, Y. L., Weiland, M., Lim, H. W., Mi, Q. S. & Zhou, L. Serum miRNA expression profiles change in autoimmune vitiligo in mice. Exp. Dermatol. 23(2), 140\u2013142 (2014).","journal-title":"Exp. Dermatol."},{"key":"83489_CR15","doi-asserted-by":"publisher","first-page":"2924","DOI":"10.1039\/c2mb25228g","volume":"8","author":"P Wang","year":"2012","unstructured":"Wang, P. et al. The changes of microRNA expression profiles and tyrosinase related proteins in MITF knocked down melanocytes. Mol. Biosyst. 8, 2924\u20132931 (2012).","journal-title":"Mol. Biosyst."},{"key":"83489_CR16","doi-asserted-by":"publisher","first-page":"105","DOI":"10.4103\/JEWD.JEWD_19_19","volume":"16","author":"AM Hassan","year":"2019","unstructured":"Hassan, A. M., Neinaa, Y. E., El-Bendary, A. S. & Zakaria, S. S. MicroRNA-146a and Forkhead box protein 3 expressions in nonsegmental vitiligo: an insight into disease pathogenesis. J. Egypt. Womens Dermatol. Soc. 16, 105\u2013111 (2019).","journal-title":"J. Egypt. Womens Dermatol. Soc."},{"key":"83489_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.genrep.2020.100955","volume":"21","author":"YW Issa","year":"2020","unstructured":"Issa, Y. W. & Salih, S. M. Impact of miR-155, miR-145 and miR-328 on pigmentary process in Iraqi patients with vitiligo. Gene Rep. 21, 100955 (2020).","journal-title":"Gene Rep."},{"key":"83489_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.843784","author":"E de Fran\u00e7a","year":"2022","unstructured":"de Fran\u00e7a, E. et al. Potential role of chronic physical exercise as a treatment in the development of vitiligo. Front. Physiol. https:\/\/doi.org\/10.3389\/fphys.2022.843784 (2022).","journal-title":"Front. Physiol."},{"issue":"6","key":"83489_CR19","doi-asserted-by":"publisher","first-page":"441","DOI":"10.5021\/ad.2020.32.6.441","volume":"32","author":"L Li","year":"2020","unstructured":"Li, L. The role of microRNAs in vitiligo: regulators and therapeutic targets. Ann. Dermatol. 32(6), 441\u2013451 (2020).","journal-title":"Ann. Dermatol."},{"issue":"6","key":"83489_CR20","first-page":"742","volume":"96","author":"L \u0160ahmatova","year":"2016","unstructured":"\u0160ahmatova, L. et al. MicroRNA-155 is dysregulated in the skin of patients with vitiligo and inhibits melanogenesis-associated genes in melanocytes and keratinocytes. Acta Dermato-venereol. 96(6), 742\u2013748 (2016).","journal-title":"Acta Dermato-venereol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-83489-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-83489-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-83489-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T19:02:36Z","timestamp":1736190156000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-83489-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,6]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["83489"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-83489-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,6]]},"assertion":[{"value":"12 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study protocol was reviewed and approved by Faculty of Medicine, Fayoum University, approval number EC-395. A written informed consent from each subject before the start of the study as well.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"1031"}}